• Patients
• Health Information
  • Central Nervous System Disorders
    • Obstructive Sleep Apnea/Hypopnea Syndrome
    • Shift Work Sleep Disorder
    • Narcolepsy
    • Epilepsy
  • Cancer
    • Acute Promyelocytic Leukemia
    • Non-Hodgkin's Lymphoma
    • Chronic Lymphocyctic Leukemia
  • Pain
    • Breakthrough Pain in Patients with Cancer
    • Muscle Spasm Associated with Musculoskeletal Conditions
• Product Information Request
• Our Products
• CephalonCares Foundation Patient Assistance Programs
• Reimbursement Assistance
• Clinical Trials Information

Home > Patients

Patients

Cephalon is dedicated to discovering and delivering new therapies to improve patient health. Whether it’s by providing patients with health information related to our products, informing them of clinical trial opportunities, or making sure those in need have access to our medicines, everything we do is motivated by a desire to make a difference in the lives of our patients.

Cephalon has a long history of leadership in developing programs to minimize potential risks associated with inappropriate use of prescription pain medicines. When Good Medicines Become Bad Drugs ^SM is a Cephalon program to educate patients, caregivers and the public about the safe and responsible use of prescription medicines.

PhRMA, the trade association representing the pharmaceutical industry, announced in 2008 a code of conduct to guide the way pharmaceutical companies interact with healthcare professionals, and ensure that all professional exchanges benefit patients and enhance the practice of medicine.  Learn about the Cephalon commitment to appropriate interactions with healthcare professionals.

Our greatest success is that there are millions of people throughout the world who benefit from our medications. They are our living legacy and the reason that we exist.